Holmium-166-radioembolization in NET After Lutetium-177-dotatate; an Efficacy Study

NCT02067988 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Neuroendocrine Tumors

Interventions

DEVICE: Holmium-166 microspheres hepatic radioembolization.

Sponsor

UMC Utrecht